Background: Laparoscopy-assisted colectomy (LAC) for p stage 0-I colon cancer (LAC0-I) has become widely accepted, in Japan, but the oncological validity of this surgery remains to be well analyzed, especially for advanced cancer, and LAC for p stage II-III colon cancer (LACII-III) is not yet accepted.
Objectives: Our objectives were to (1) compare LAC0-I and LACII-III safety and efficacy for sigmoid colon based on clinical outcome, i.e., intraoperative findings and perioperative and postoperative course, and (2) assess the oncological outcomes of LAP for p stage II-III sigmoid colon cancer.
Methods: Subjects were 996 persons undergoing laparoscopic colorectal cancer surgery between March 1994 and January 2009. The cases of 231 cases whose pathological findings were curability A stage 0-III sigmoid colon cancer (0/I/II/IIIa/IIIb=17/81/68/41/24) were included in this study.
Results: No significant statistical difference was seen in demographic data between LAC0-I and II-III. In LN dissection, LACII-III subjects required more D3. Results for other clinical outcomes were similar in both groups. Overall and disease-free 5-year survival was 100/99% in stage I, 96/94% in stage II, 93/89% in stage IIIa, and 85/76% in stage IIIb.
Conclusions: Although further evaluation is required, laparoscopic surgery for p stage II/III sigmoid colon cancer appears to be safe, and oncologically adequate in treating colon cancer.
View full abstract